651
Participants
Start Date
June 8, 2022
Primary Completion Date
October 31, 2026
Study Completion Date
October 31, 2026
ASP3082
Intravenous Infusion
Cetuximab
Intravenous Infusion
Leucovorin
Intravenous Infusion
Oxaplatin
Intravenous Infusion
Fluorouracil
Intravenous Infusion
Irinotecan
Intravenous Infusion
Nanoparticle albumin-bound-paclitaxel
Intravenous Infusion
Gemcitabine
Intravenous Infusion
Docetaxel
Intravenous Infusion
Pembrolizumab
Intravenous Infusion
Cisplatin
Intravenous Infusion
Carboplatin
Intravenous Infusion
Pemetrexed
Intravenous Infusion
RECRUITING
Columbia University - Herbert Irving Comprehensive Cancer Center, New York
RECRUITING
Memorial Sloan Kettering Cancer Center, New York
RECRUITING
Roswell Park Cancer Institute, Buffalo
RECRUITING
Georgetown University Hospital, Washington D.C.
RECRUITING
NEXT Oncology - Virginia Cancer Specialists, Fairfax
RECRUITING
University of Florida, Davis Cancer Center, Gainesville
RECRUITING
Florida Cancer Specialist, Lake Mary
TERMINATED
SCRI Oncology Partners, Nashville
RECRUITING
Vanderbilt University Medical Center, Nashville
RECRUITING
Case Western, Cleveland
RECRUITING
University of Wisconsin Hospital, Madison
RECRUITING
Washington University School of Medicine, St Louis
RECRUITING
University of Kansas Medical Center, Westwood
RECRUITING
NEXT Oncology, San Antonio
RECRUITING
Denver HealthONE Drug Development Unit, Denver
RECRUITING
UCLA Santa Monica Hematology Oncology, Santa Monica
RECRUITING
City of Hope National Medical Center, Duarte
RECRUITING
Oregon Health and Science University, Portland
RECRUITING
Smilow Cancer Center at Yale New Haven Hospital, New Haven
RECRUITING
Florida Cancer Specialists & Research Institute Sarasota, Sarasota
RECRUITING
Beth Israel Deaconess Medical Center, Boston
RECRUITING
Dana Farber Cancer Institute, Boston
RECRUITING
Beijing Cancer Hospital, Beijing
RECRUITING
Fudan University Shanghai Cancer Center, Xuhui District
RECRUITING
Site FR33003, La Tronche
RECRUITING
Site FR33002, Bordeaux
RECRUITING
Site FR33001, Lyon
RECRUITING
Site FR33005, Lyon
RECRUITING
Site FR33004, Villejuif
RECRUITING
Aichi Cancer Center, Nagoya
RECRUITING
National Cancer Center Hospital East, Kashiwa
RECRUITING
Shikoku Cancer Center, Matsuyama
RECRUITING
Hokkaido University Hospital, Sapporo
RECRUITING
Kanagawa Cancer Center, Yokohama
RECRUITING
Tohoku University Hospital, Sendai
RECRUITING
Kindai University Hospital, Sayama
RECRUITING
Shizuoka Cancer Center, Sunto-gun
RECRUITING
National Cancer Center Hospital, Chuo-ku
RECRUITING
Cancer Institute Hospital of JFCR, Koto-ku
RECRUITING
Yamaguchi University Hospital, Ube
RECRUITING
Osaka International Cancer Institute, Osaka
RECRUITING
Site KR82002, Seongnam-si
RECRUITING
Site KR82001, Jongno -Gu
RECRUITING
Site KR82003, Seodaemun-gu
RECRUITING
Site KR82004, Songpa-gu
RECRUITING
Site ES34001, Barcelona
RECRUITING
Site ES34004, Madrid
RECRUITING
Site ES34002, Málaga
RECRUITING
Site ES34003, Seville
Lead Sponsor
Astellas Pharma Inc
INDUSTRY